成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Wuhan Jingkangen Biomedical Technology Co., Ltd

Firmenname:Wuhan Jingkangen Biomedical Technology Co., Ltd
Telefon:13720134139 +86 -0-15871494362
E-Mail:orders@jknbiochem.com
Nationalit?t:China
URL: www.jknbiochem.com
Produkte insgesamt:5821
5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59

Produktkatalog

Ozoralizumab1167985-17-2
Drozitumab912628-39-8
Roledumab1174008-79-7
Blosozumab1132758-87-2
Sirukumab1194585-53-9
Enoticumab1192578-27-0
Ocaratuzumab1169956-08-4
Bimagrumab1356922-05-8
Lodelcizumab1355338-54-3
Bectumomab158318-63-9
Secukinumab1229022-83-6
Rontalizumab948570-30-7
Dalotuzumab1005389-60-5
Icrucumab1024603-92-6
Tregalizumab1207446-68-1
Flanvotumab1188277-05-5
Clazakizumab1236278-28-6
Nesvacumab1296818-77-3
Daratumumab945721-28-8
Lirilumab1000676-41-4
Sifalimumab1006877-41-3
Enokizumab909875-08-7
Onartuzumab1133766-06-9
Indatuximab Ravtansine1238517-16-2
Quilizumab1228538-47-3
Placulumab945781-29-3
Concizumab1312299-39-0
Maslimomab127757-92-0
Minretumomab195189-17-4
Samalizumab1073059-33-2
Pidilizumab1036730-42-3
Vepalimomab195158-85-1
Ensituximab1092658-06-4
Atinumab1226761-65-4
Crenezumab1095207-05-8
Tabalumab1143503-67-6
Fasinumab1190239-42-9
Orticumab1314241-10-5
Pinatuzumab Vedotin1313706-14-7
Zolimomabaritox141483-72-9
Nerelimomab162774-06-3
Alirocumab1245916-14-6
Rilotumumab872514-65-3
Mavrilimumab1085337-57-0
Olokizumab1007223-17-7
Ublituximab1174014-05-1
Narnatumab1188275-92-4
Imgatuzumab959963-46-3
Ozanezumab1310680-64-8
Pritoxaximab1351470-16-0
Lampalizumab1278466-20-8
Vedolizumab943609-66-3
Romosozumab909395-70-6
Mogamulizumab1159266-37-1
Benralizumab1044511-01-4
Fezakinumab1007106-86-6
Suvizumab914257-21-9
Etrolizumab1044758-60-2
Ponezumab1178862-65-1
Caplacizumab915810-67-2
Actoxumab1245634-25-6
Simtuzumab1318075-13-6
Tildrakizumab1326244-10-3
Foralumab946415-64-1
Carlumab915404-94-3
Ficlatuzumab1174900-84-5
Vatelizumab1238217-55-4
Futuximab1310460-85-5
Parsatuzumab1312797-14-0
Solanezumab955085-14-0
Evolocumab1256937-27-5
Patritumab1262787-83-6
Rovelizumab339086-79-2
Teprotumumab1036734-93-6
Oxelumab1186098-83-8
Vesencumab1205533-60-3
Pateclizumab1202526-59-7
Duligotuzumab1314238-96-4
Ligelizumab1322627-61-1
Seribantumab1334296-12-6
Setoxaximab1351470-17-1
Nacolomab Tafenatox150631-27-9
Urelumab934823-49-1
Olaratumab1024603-93-7
Lebrikizumab953400-68-5
Glembatumumab1020264-78-1
Fulranumab902141-80-4
Radretumab1253180-81-2
Bezlotoxumab1246264-45-8
Vorsetuzumab1165740-62-4
Dusigitumab1204390-13-5
Itolizumab1116433-11-4
Brodalumab1174395-19-7
Intetumumab725735-28-4
Girentuximab916138-87-9
Enavatuzumab1062149-33-0
Namilumab1206681-39-1
Solitomab1005198-65-1
Perakizumab1331830-76-2
Modotuximab1310460-86-6
5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
Copyright 2019 ? ChemicalBook. All rights reserved